Emmes

Jan 16, 2025

Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma

Dec 10, 2024

Emmes adds new role as it looks to expand government footprint

Sep 04, 2024

Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA's clinical trials network

Feb 22, 2021

Emmes Employees Co-Author Substance Use Article for the New England Journal of Medicine

Feb 08, 2021

Emmes Employees Contribute to New England Journal of Medicine Report on Pregnant Women with Epilepsy

Dec 30, 2020

Emmes Acquires Neox s.r.o., a Clinical Research Organization Headquartered in the Czech Republic

Dec 14, 2020

Emmes Announces its Contribution to Second Remdesivir Clinical Trial for COVID-19

Nov 02, 2020

Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine

Oct 29, 2020

Emmes Selected as Corporate Achievement Award Winner by the Montgomery County Chamber of Commerce

Aug 12, 2020

Emmes Announces its Role in Phase 1 COVID-19 Vaccine Trial

Aug 06, 2020

Emmes Promotes Three VPs to Officer Positions

Jun 17, 2020

Emmes Chosen as a Top Area Workplace

Jun 15, 2020

Emmes Announces Its Work on a Phase 3 Clinical Trial for Breakthrough Therapy Designation Product

May 26, 2020

Emmes Announces its Contribution to NIH ACTT Clinical Trial for Remdesivir

May 04, 2020

Emmes Announces Dr. Joe Sliman as New Chief Medical Officer

Apr 06, 2020

Three Long-Time Emmes Employees Are Named VPs